Last reviewed · How we verify
NCT05991596
Vitiligo and Psychodrama Therapy
NA trial testing Psychodramatic psychotherapy in Vitiligo in 7 participants. Completed in 11 May 2024.
11 May 2024
Quick facts
| Lead sponsor | Azienda Sanitaria Universitaria Integrata del Trentino |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 7 |
| Start date | 2 November 2023 |
| Primary completion | 11 May 2024 |
| Estimated completion | 11 May 2024 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Psychodramatic psychotherapy
- Self-help activities
Conditions studied
- Vitiligo — all drugs for Vitiligo →
Sponsor
Azienda Sanitaria Universitaria Integrata del Trentino
Who can join
Adults 18 to 55, any sex, with Vitiligo. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this pilot clinical trial is to assess the effectiveness of psychodramatic psychotherapy in reducing the psychological distress and/or the skin condition in patients with vitiligo. The main questions it aims to answer are: 1. Is there any improvement in terms of psychological distress in patients with vitiligo participating in a psychodramatic psychotherapy, compared to a control group? 2. Is there any improvement in terms of skin condition in patients with vitiligo participating in a psychodramatic psychotherapy, compared to a control group? Participants in the experimental group will receive the dermatological drug treatment usually recommended for vitiligo, and in addition they will participate in a 6 months psychodramatic psychotherapy. Researchers will compare the results of the experimental group with the results of a control group including vitiligo patients who will receive the dermatological pharmacological treatment usually recommended for vitiligo and participate in a 6 months program of self-help activities.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Recent Advances in Vitiligo Treatment.
Qiu Y, Su X, Chen J, Jiang S, et al · · 2026 · PMID 41940356 · DOI 10.2147/itt.s577653
Verify or expand the search:
- PubMed search for NCT05991596
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Vitiligo
Currently open trials in the same condition.
- NCT07153666 — A Real-world Study on the Influencing Factors of Efficacy of Ruxolitinib Cream in Vitiligo · recruiting
- NCT07267273 — Betamethasone Phonophoresis For Vitiligo · NA · recruiting
- NCT07232238 — TRPM2 Gene Polymorphism, NLRP3 Inflammasome Expression in Vitiligo Patients · active not recruiting
- NCT07532330 — Tyrosine Vs Tacrolimus With NB-UVB in Vitiligo · NA · active not recruiting
- NCT07357870 — A Proof of Concept, Phase 1 Study of CGB-600 for the Topical Treatment of Non-Segmented Facial Vitiligo · Phase 1 · recruiting
Other Azienda Sanitaria Universitaria Integrata del Trentino trials
Trials by the same sponsor.
- NCT06835595 — TMS-related Measures as Biomarker of Cognitive Impairment in PD · NA · recruiting
- NCT07310641 — Descriptive Analysis of Preimplantation Genetic Test (PGT)in Couples With Polycystic Kidney Disease (PKD). In the ADPKD · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05991596 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Azienda Sanitaria Universitaria Integrata del Trentino
- Last refreshed: 20 June 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05991596.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing